Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
The New England Journal of Medicine
|
July 24, 2024
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
Raphael J Landovitz, Sinead Delany-Moretlwe, Jessica M Fogel, et al.
AIDS Research and Human Retroviruses
|
April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States
Iris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
Journal of the International AIDS Society
|
October 31, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084
Mark A Marzinke, Brett Hanscom, Daniel Haines, et al.
AIDS (London, England)
|
November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs
Oleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Gynecologic Oncology
|
April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation
G Larry Maxwell, Brian L Hood, Roger Day, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 26, 2022
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations
Brittany A Petros, Jacquelyn Turcinovic, Nicole L Welch, et al.
Journal of the International AIDS Society
|
October 24, 2018
Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis
Kathryn E Lancaster, Irving F Hoffman, Brett Hanscom, et al.
Lancet (London, England)
|
April 4, 2022
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
Sinead Delany-Moretlwe, James P Hughes, Peter Bock, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
The New England Journal of Medicine
|
July 24, 2024
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis
Raphael J Landovitz, Sinead Delany-Moretlwe, Jessica M Fogel, et al.
AIDS Research and Human Retroviruses
|
April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States
Iris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
Journal of the International AIDS Society
|
October 31, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084
Mark A Marzinke, Brett Hanscom, Daniel Haines, et al.
AIDS (London, England)
|
November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs
Oleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Gynecologic Oncology
|
April 5, 2011
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation
G Larry Maxwell, Brian L Hood, Roger Day, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 26, 2022
Early Introduction and Rise of the Omicron Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant in Highly Vaccinated University Populations
Brittany A Petros, Jacquelyn Turcinovic, Nicole L Welch, et al.
Journal of the International AIDS Society
|
October 24, 2018
Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis
Kathryn E Lancaster, Irving F Hoffman, Brett Hanscom, et al.
Lancet (London, England)
|
April 4, 2022
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial
Sinead Delany-Moretlwe, James P Hughes, Peter Bock, et al.
Page
of 7